drug · antibody
vamikibart
Phase 3updated 3mo agoby F. Hoffmann-La Roche Ltd🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying vamikibart
- phase2A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema
- phase3Vamikibart in Participants With Uveitic Macular Edema
- phase3A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema
- phase2A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 37m ago
Found something off?
comments(0)
5-min edit window · permanent after that